Literature DB >> 1959993

Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.

S Aaltomaa1, P Lipponen, M Eskelinen, V M Kosma, S Marin, E Alhava, K Syrjänen.   

Abstract

Clinical features, 8 histological features, 7 nuclear morphometric variables and 2 mitotic indices were entered in a Cox's model to assess their independent predictive power in a series of 517 breast cancer patients followed up for over 10 years. The volume-corrected mitotic index (M/V index) (p less than 0.001), axillary lymph-node status (p = 0.002), the shortest nuclear axis (p = 0.006) and the degree of tubule formation (p = 0.02) predicted independently the recurrence-free survival. In N- tumours (n = 293), the M/V index (p = 0.005), the degree of tubule formation (p = 0.016) and tumour size (p = 0.023) were independent prognostic predictors, whereas in N+ tumours (n = 224), only the M/V index (p = 0.004) and the maximum nuclear axis (p = 0.004) had independent prognostic value. The corrected survival was predicted independently by the axillary lymph-node status, degree of tubule formation, M/V index, tumour size (p less than 0.001), age (p = 0.002) and year of treatment (p = 0.008). In N- tumours, the degree of tubule formation (p = 0.005) and intraductal growth pattern (p = 0.015) exhibited independent predictive value. In N+ tumours, patient survival was related to the M/V index (p less than 0.001), tumour size (p = 0.005) and patient age (p = 0.005). The results show that the assessment of the M/V index, axillary lymph-node status, tumour size, intraductal growth pattern and tubule formation are reliable factors in predicting the prognosis of breast cancer. The conventional mitotic activity index (MAI) and histological grading should be replaced by the M/V index in histological assessment of malignancy in breast cancer. The prognostic scores combining the independent variables reflecting the proliferative rate and metastatic potential of the tumours are more accurate predictors of the recurrence-free survival and overall survival (p less than 0.0001) than the single variables used alone.

Entities:  

Mesh:

Year:  1991        PMID: 1959993     DOI: 10.1002/ijc.2910490615

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; H K Haapasalo; S Nordling; P Rajala
Journal:  Urol Res       Date:  1996

2.  The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.

Authors:  T Pietiläinen; P Lipponen; S Aaltomaa; M Eskelinen; V M Kosma; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Authors:  P Lipponen; H Ji; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.

Authors:  S Aaltomaa; P Lipponen; S Papinaho; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

6.  Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.

Authors:  P K Lipponen; M J Eskelinen; K Jauhiainen; E Harju; P Terho; H Haapasalo
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  Nuclear morphometry in relation to lymph node status in canine mammary carcinomas.

Authors:  G De Vico; P Maiolino; M Cataldi; G Mazzullo; B Restucci
Journal:  Vet Res Commun       Date:  2007-02-05       Impact factor: 2.816

8.  Prognosis based on primary breast carcinoma instead of pathological nodal status.

Authors:  S Ménard; R Bufalino; F Rilke; N Cascinelli; U Veronesi; M I Colnaghi
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

9.  Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.

Authors:  S Vesalainen; S Nordling; P Lipponen; M Talja; K Syrjänen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.